AstraZeneca, Handa fail to get out of US antitrust case over Seroquel XR
MLex Summary: AstraZeneca, Handa Pharmaceuticals and Par Pharmaceuticals must face US antitrust claims over an alleged reverse payment concerning Seroquel XR, a federal judge ruled. District Judge Colm F. Connolly said...To view the full article, register now.
Already a subscriber? Click here to view full article